The global nootropics market is projected to accomplish extraordinary growth in the forecast period, 2023-2027, with an impressive CAGR. The market growth can be attributed to the surging demands for the drugs and pharmaceuticals that support the brain’s cognitive functions. Moreover, the rapidly increasing demand for brain boosters and smart drugs among the student population is driving the growth of the global nootropics market in the upcoming five years.

The students are inclined toward nootropics for its qualities like improving cognitive function, such as executive functions, memory, creativity, or motivation. The rising awareness about these drugs is supporting the growth of the global nootropics market in the next five years. However, the ethical issues regarding the use of nootropics drugs by healthy individuals may put some restraint over the growth of the global nootropics market in the future.

In the year, 2020 the United States Food and Drug Administration and Federal Trade Commission warned the manufacturers and market players involved in the advertisements about the probable advertisement fraud and marketing scams related to nootropics substances. The issue of substance issues is also a major concern toward the drug, although regulatory sales and prospective warnings are anticipated to support the future growth of the global nootropics market in the future five years of the forecast, until 2027.

Nootropics are the drugs, supplements, and related components that are expected to work efficiently in increasing and enhancing brain activities like cognitive thinking, executive functioning of the brain, higher memory retention, and creating senses of healthy motivation for the individuals. Patients suffering from mood swings, depression, lack of attention and focus, and sleep disorders are often prescribed nootropics for their recovery. The substance is often associated with the term “smart drugs” for their functions and effects they produce over the consumer.

The global nootropics market is segmented by type, product type, distribution channel, application channel, regional distribution, and competitional analysis. Based on type, the market is further differentiated between prescription and over-the-counter nootropics drugs. Prescription nootropics drugs are anticipated to hold the largest revenue shares of the market and assert their dominance over the market segment in the upcoming five years on account of rapidly increasing cases of depression, mood swings, anxiety, and stress.

The patients suffering from such mental health issues are able to control their symptoms, and these drugs help them to facilitate their thoughts. Also, concerning legalities and ethical issues have made it essential for the prescription to e produced to purchase the nootropics drugs, thereby supporting the growth of the global nootropics market in the next five years.

Holding the major shares of the global nootropics market are Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN), among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through nootropics drugs. Further advancement would aid the market value and brand establishment in the future five years.

Objective of the Study:

  • To analyze the historical growth of the market size of global nootropics market from 2017 to 2020.
  • To estimate and forecast the market size of global nootropics market from 2021 to 2027 and growth rate until 2027. 
  • To classify and forecast global nootropics market based on type, product type, distribution channel, applications, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global nootropics market.
  • To identify drivers and challenges for global nootropics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nootropics market.
  • To identify and analyze the profile of leading players operating in global nootropics market.
  • To identify key sustainable strategies adopted by market players in global nootropics market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global nootropics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to nootropics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         Product Type

·         Distribution Channel

·         Application

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Kuwait, Brazil, Argentina, Colombia

Key companies profiled

Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN).

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global nootropics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Nootropics Market, By Type:
    • Prescription
    • Over the Counter
  • Global Nootropics Market, By Product Type:
    • Natural
    • Synthetic
  • Global Nootropics Market, By Distribution Channel:
    • Online
    • Offline
  • Global Nootropics Market, By Application:
    • Memory Enhancement
    • Mood & Depression
    • Attention & Focus
    • Longevity & Anti-aging
    • Sleep & Recovery
    • Anxiety
    • Others
  • Global Nootropics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nootropics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Nootropics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Nootropics Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Nootropics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Prescription v/s Over the Counter)

6.2.2.     By Product Type (Natural v/s Synthetic)

6.2.3.     By Distribution Channel (Online v/s Offline)

6.2.4.     By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    North America Nootropics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Product Type

7.2.3.     By Distribution Channel

7.2.4.     By Application

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Nootropics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Product Type

7.3.1.2.3.             By Distribution Channel

7.3.1.2.4.             By Application

7.3.2.     Mexico Nootropics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Product Type

7.3.2.2.3.             By Distribution Channel

7.3.2.2.4.             By Application

7.3.3.     Canada Nootropics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Product Type

7.3.3.2.3.             By Distribution Channel

7.3.3.2.4.             By Application

8.    Europe Nootropics Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Product Type

8.2.3.     By Distribution Channel

8.2.4.     By Application

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Nootropics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Product Type

8.3.1.2.3.             By Distribution Channel

8.3.1.2.4.             By Application

8.3.2.     United Kingdom Nootropics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Product Type

8.3.2.2.3.             By Distribution Channel

8.3.2.2.4.             By Application

8.3.3.     Italy Nootropics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Product Type

8.3.3.2.3.             By Distribution Channel

8.3.3.2.4.             By Application

8.3.4.     Germany Nootropics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Product Type

8.3.4.2.3.             By Distribution Channel

8.3.4.2.4.             By Application

8.3.5.     Spain Nootropics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Product Type

8.3.5.2.3.             By Distribution Channel

8.3.5.2.4.             By Application

9.    Asia-Pacific Nootropics Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Product Type

9.2.3.     By Distribution Channel

9.2.4.     By Application

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Nootropics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Product Type

9.3.1.2.3.             By Distribution Channel

9.3.1.2.4.             By Application

9.3.2.     India Nootropics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Product Type

9.3.2.2.3.             By Distribution Channel

9.3.2.2.4.             By Application

9.3.3.     Japan Nootropics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Product Type

9.3.3.2.3.             By Distribution Channel

9.3.3.2.4.             By Application

9.3.4.     Australia Nootropics Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Product Type

9.3.4.2.3.             By Distribution Channel

9.3.4.2.4.             By Application

9.3.5.     South Korea Nootropics Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Product Type

9.3.5.2.3.             By Distribution Channel

9.3.5.2.4.             By Application

10.  South America Nootropics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Product Type

10.2.3.  By Distribution Channel

10.2.4.  By Application

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Nootropics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Product Type

10.3.1.2.3.           By Distribution Channel

10.3.1.2.4.           By Application

10.3.2.  Argentina Nootropics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Product Type

10.3.2.2.3.           By Distribution Channel

10.3.2.2.4.           By Application

10.3.3.  Colombia Nootropics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Product Type

10.3.3.2.3.           By Distribution Channel

10.3.3.2.4.           By Application

11.  Middle East and Africa Nootropics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Product Type

11.2.3.  By Distribution Channel

11.2.4.  By Application

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Nootropics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Product Type

11.3.1.2.3.           By Distribution Channel

11.3.1.2.4.           By Application

11.3.2.  UAE Nootropics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Product Type

11.3.2.2.3.           By Distribution Channel

11.3.2.2.4.           By Application

11.3.3.  Saudi Arabia Nootropics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Product Type

11.3.3.2.3.           By Distribution Channel

11.3.3.2.4.           By Application

11.3.4.  Kuwait Nootropics Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Product Type

11.3.4.2.3.           By Distribution Channel

11.3.4.2.4.           By Application

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Accelerated Intelligence Inc.

14.2.              AlternaScript LLC

14.3.              Onnit Labs, Inc.

14.4.              Peak Nootropics LLC

14.5.              Teva Pharmaceutical Industries Ltd.

14.6.              Purelife bioscience Co., Ltd

14.7.              SupNootropic bio co., Ltd

14.8.              Cephalon, Inc.

14.9.              United Pharmacies (UK) Ltd.

14.10.            Nootrobox Inc. (HVMN)

15.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com